LONDON – Medalliance SA says its sirolimus-coated balloon catheter for the treatment of coronary artery disease will be in U.S. patients this time next year, after the device was awarded a U.S. FDA breakthrough device designation. The device, called Selution, uses biodegradable polymer micro reservoirs to hold sirolimus, enabling the anti-restenotic drug to be released in a controlled and sustained way. Read More
Sleep is universal on both the species and the individual level. Though there have been reports of individuals, both in humans and other species, who need almost no sleep, a truly sleepless individual has never been identified. Read More
